Early serum β-human chorionic gonadotropin in pregnancies after in vitro fertilization: contribution of treatment variables and prediction of long-term.

Slides:



Advertisements
Similar presentations
Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T
Advertisements

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
Ratio between inner cell mass diameter and blastocyst diameter is correlated with successful pregnancy outcomes of single blastocyst transfers  Miriam.
Knut Gjelland, M. D. , Seth Granberg, M. D. , Ph. D
Fertility and Sterility  Volume 97, Issue 3, Pages (March 2012)
Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States  Jennifer.
Michael M. Alper, M.D.  Fertility and Sterility 
Effect of a very-low-calorie diet on in vitro fertilization outcomes
Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 
Human chorionic gonadotropin ratio of hemoperitoneum versus venous serum improves early diagnosis of ectopic pregnancy  YuDong Wang, M.D., Hong Zhao,
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 
Early loss rates of entire pregnancies after assisted reproduction are lower in twin than in singleton pregnancies  Alexandra Matias, M.D., Giovanni B.
Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study  Leonidas Mamas, M.D., Ph.D. 
Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy  Ewa Nowak-Markwitz,
Medical treatment of ectopic pregnancy: a committee opinion
Craig A. H Richard, Ph. D. , Carolyn J Kubik, M. D
Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.
Human chorionic gonadotropin as a predictor of outcome in assisted reproductive technology pregnancies  Gillian Homan, Susan Brown, R.N., John Moran,
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Martin D. Keltz, M. D. , Josh C. Skorupski, M. D. , Katrina Bradley, M
How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity  Katherine.
Alka Prakash, M. D. , Susan Laird, Ph. D. , Elizabeth Tuckerman, M. Sc
Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review  Seema Menon, M.D., John.
Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T
Robert F. Casper, M.D.  Fertility and Sterility 
Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to.
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization  Laura Detti, M.D., Daniel B. Williams, M.D., Jared.
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization  Thomas Brodin,
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Modulation of HOXA10 and other markers of endometrial receptivity by age and human chorionic gonadotropin in an endometrial explant model  Robin H. Fogle,
Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles  Karin.
Prediction of pregnancy rate by blastocyst morphological score and age, based on 1,488 single frozen-thawed blastocyst transfer cycles  Sakae Goto, M.D.,
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.
Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection  Dorothea M.
Pete N. Lohstroh, B. S. , James W. Overstreet, M. D. , Ph. D
Tal Imbar, M.D., Arye Hurwitz, M.D.  Fertility and Sterility 
“Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss  Michelle.
David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F
Difference between serum beta-human chorionic gonadotropin levels in pregnancies after in vitro maturation and in vitro fertilization treatments  Benny.
Antoni J. Duleba, M.D., Ibrahim M. Ahmed, M.D.  Fertility and Sterility 
Fertility and Sterility
Aviad Cohen, M. D. , Guy Bibi, M. D. , Benny Almog, M. D
Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D
Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome?  Luis.
Kayoko Takata, M. D. , Nobuhiko Suganuma, M. D. , Hisae Wada, M. D
A mandatory single blastocyst transfer policy with educational campaign in a United States IVF program reduces multiple gestation rates without sacrificing.
Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization  David W. Schmidt, M.D.,,
Fertility and Sterility: an evaluation
Failed IVF cycles and the risk of subsequent preeclampsia or fetal growth restriction: a case-control exploratory study  Ioanna Tsoumpou, M.D., Ahmed.
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.
Hourly human chorionic gonadotropin secretion profiles during the peri-implantation period of successful pregnancies  Pete N. Lohstroh, Ph.D, James W.
Use of serum inhibin A and human chorionic gonadotropin measurements to predict the outcome of in vitro fertilization pregnancies  Erik Hauzman, M.D.,
Fertility and Sterility
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
In vitro sildenafil citrate use as a sperm motility stimulant
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders  Hakan Cakmak, M.D., Nam D. Tran,
Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient’s body mass index and the number of larger follicles 
In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation 
Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization:
Hyperglycosylated human chorionic gonadotropin as an early predictor of pregnancy outcomes after in vitro fertilization  Sandy Chuan, M.D., Michael Homer,
Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society.
Presentation transcript:

Early serum β-human chorionic gonadotropin in pregnancies after in vitro fertilization: contribution of treatment variables and prediction of long-term pregnancy outcome  Shay Porat, M.D., Stephan Savchev, M.D., Yuval Bdolah, M.D., Arye Hurwitz, M.D., Ronit Haimov-Kochman, M.D.  Fertility and Sterility  Volume 88, Issue 1, Pages 82-89 (July 2007) DOI: 10.1016/j.fertnstert.2006.11.116 Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

FIGURE 1 Pregnancy success shows linear correlation with initial βhCG level 13 days after ET with a coefficient of the linear model of 1.0668 (P<.0001). βhCG quartiles: first quartile: 0–62 mIU/mL (n = 134), second quartile: 63–141 mIU/mL (n = 134), third quartile: 142–297 mIU/mL (n = 132), fourth quartile: 298–3,047 mIU/mL (n = 133). The odds ratio was 2.906 for each increase in the βhCG quartile. Porat. Low initial ahCG in IVF cycles. Fertil Steril 2007. Fertility and Sterility 2007 88, 82-89DOI: (10.1016/j.fertnstert.2006.11.116) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

FIGURE 2 Pregnancy success rate is correlated with early embryonic developmental delay both in the study group and the control group. The difference in days between calculated embryonic age and actual embryonic age as derived from measured CRL is represented in the x-axis. Porat. Low initial ahCG in IVF cycles. Fertil Steril 2007. Fertility and Sterility 2007 88, 82-89DOI: (10.1016/j.fertnstert.2006.11.116) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

FIGURE 3 Comparison of preterm deliveries rate in study and control groups. P values are shown. Porat. Low initial ahCG in IVF cycles. Fertil Steril 2007. Fertility and Sterility 2007 88, 82-89DOI: (10.1016/j.fertnstert.2006.11.116) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions